positions available now

Tag Archives: Bioequivalence Studies

Using an overseas reference product in your bioequivalence studies

It is the TGA’s preference that bioequivalence (BE) studies to support generic medicines are performed using the Australian (AU) innovator product as the reference; however, within certain TGA conditions, it is possible to use an overseas reference/innovator product in your … Continue reading

Posted in Life Sciences Industry, Regulatory Services, TGA | Tagged , | Comments Off on Using an overseas reference product in your bioequivalence studies
Copyright © 2014 Commercial Eyes